Sally Barrington

From Wikipedia, the free encyclopedia

Sally Barrington is a professor of positron emission tomography (PET) Imaging and National Institute for Health Research (NIHR) research professor at King's College London (KCL), England, United Kingdom.[1] She joined KCL in 1993.

Biography[edit]

Barrington obtained her nuclear medicine training at the Guy's and St Thomas’ Hospital London, where she was later appointed as a consultant in 1998.

Her research is focused on the study of lymphoma cancer and radiotherapy planning using PET imaging.[1] She has been involved in numerous multicentre clinical trials. She has also work experience in other clinical areas, including, but not limited to, oncology, neurology, cardiology and infection/inflammation. She co-leads the UK PET Research Network.[2]

In 2019, Barrington was awarded the British Nuclear Medicine Society (BNMS) Roll of Honour.[3] Barrington sits on the Editorial Board of Journal of Clinical Oncology; she is the chair of the National Institute for Health Research Academy Involvement Group and the Radiation Safety Committee of Guy's and St Thomas' NHS Foundation Trust.[4] She is a member of various professional organisations, including the Scientific Committee for international workshops on PET in lymphoma, European Lymphoma Institute, Administration of Radioactive Substances Advisory Committee (ARSAC), CRUK Expert Review Panel, Oncology Committee of the European Association of Nuclear Medicine, and National Cancer Research Institute (NCRI) Clinical Studies Group in Lymphoma.[5]

Selected publications[edit]

Scientific journal papers[edit]

  • 1980 citations: Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification.[6]
  • 1133 citations: FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.[7]
  • 926 citations: Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group.[8]

Books edited[edit]

  • 1999: Atlas of Clinical Positron Emission Tomography: By R. Wahl, S. Barrington, M. Maisey. CRC Press.[9]
  • 2005: Atlas of Clinical Positron Emission Tomography 2nd Edition: By R. Wahl, S. Barrington, M. Maisey. Hodder Education.[10]

Book chapters[edit]

  • Chapter 20 in PET/MRI in Oncology: Current Clinical Applications edited by Andrei Iagaru, Thomas Hope, Patrick Veit-Haibach.[11]
  • Chapter 8 in Radiotherapy for Hodgkin Lymphoma edited by Lena Specht, Joachim Yahalom.[12]

References[edit]

  1. ^ a b "Professor Sally Barrington". www.kcl.ac.uk. Retrieved 2020-07-22.
  2. ^ "NCRI PET Core Lab - Structure". www.ncri-pet.org.uk. Retrieved 2020-07-22.
  3. ^ "BNMS Roll of Honour - British Nuclear Medicine Society". www.bnms.org.uk. Retrieved 2020-07-22.
  4. ^ "Sally Barrington - Biography - Research Portal, King's College, London". kclpure.kcl.ac.uk. Retrieved 2020-07-22.
  5. ^ "Sally Barrington - Biography - Research Portal, King's College, London". kclpure.kcl.ac.uk. Retrieved 2020-07-22.
  6. ^ Cheson, Bruce D.; Fisher, Richard I.; Barrington, Sally F.; Cavalli, Franco; Schwartz, Lawrence H.; Zucca, Emanuele; Lister, T. Andrew (2014-09-20). "Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification". Journal of Clinical Oncology. 32 (27): 3059–3067. doi:10.1200/jco.2013.54.8800. ISSN 0732-183X. PMC 4979083. PMID 25113753.
  7. ^ Boellaard, Ronald; O’Doherty, Mike J; Chiti, Arturo; Krause, Bernd J. (2010-05-26). "Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging". European Journal of Nuclear Medicine and Molecular Imaging. 37 (7): 1432–1433. doi:10.1007/s00259-010-1459-4. ISSN 1619-7070. PMC 2886119.
  8. ^ Barrington, Sally F.; Mikhaeel, N. George; Kostakoglu, Lale; Meignan, Michel; Hutchings, Martin; Müeller, Stefan P.; Schwartz, Lawrence H.; Zucca, Emanuele; Fisher, Richard I.; Trotman, Judith; Hoekstra, Otto S. (2014-09-20). "Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group". Journal of Clinical Oncology. 32 (27): 3048–3058. doi:10.1200/jco.2013.53.5229. ISSN 0732-183X. PMC 5015423. PMID 25113771.
  9. ^ Barrington, Sally (2005-11-25). Atlas of Clinical Positron Emission Tomography. CRC Press. doi:10.1201/b13518. ISBN 978-0-429-10123-6. S2CID 70590731.
  10. ^ Barrington, Sally. (2005). Atlas of Clinical Positron Emission Tomography 2nd Edition. Hodder Education. OCLC 746577890.
  11. ^ Iagaru, Andrei, Sonstige. Hope, Thomas, Sonstige. Veit-Haibach, Patrick, Sonstige. (23 January 2018). PET/MRI in Oncology : Current Clinical Applications. ISBN 978-3-319-68517-5. OCLC 1021387143.{{cite book}}: CS1 maint: multiple names: authors list (link)
  12. ^ Specht, Lena; Yahalom, Joachim, eds. (2011). Radiotherapy for Hodgkin Lymphoma. doi:10.1007/978-3-540-78944-4. ISBN 978-3-540-78455-5.


Stub icon

This biographical article related to medicine is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Sally_Barrington&oldid=1131131432"